A multicenter non-inferior randomized controlled study comparing the efficacy of laparoscopic versus abdominal radical hysterectomy for cervical cancer (stages IB1, IB2, and IIA1): study protocol of the LAUNCH 2 trial | |
Wu, Xin1; Qiu, Ling1; Lou, Weihua2; Wang, Xipeng3; Zhu, Tao4; Zhang, Yuyang5; Hu, Weiguo1; Xue, Xiaohong1; Zhu, Zhiling1; Xiang, Libing6 | |
刊名 | TRIALS |
2022-04-08 | |
卷号 | 23 |
关键词 | Cervical cancer Stages IB1 IB2 and IIA1 Laparoscopic radical hysterectomy Abdominal radical hysterectomy Randomized controlled trials Progression-free survival Overall survival Prognosis |
DOI | 10.1186/s13063-022-06245-5 |
通讯作者 | Du, Yan(sophiedu_61@163.com) ; Jiang, Hua(jianghua@fudan.edu.cn) |
英文摘要 | Background: A retrospective study and a randomized controlled trial published in late 2018 have shown that laparoscopic radical hysterectomy (RH) was associated with worse survival than abdominal RH among patients with early-stage cervical cancer. Radical hysterectomy in cervical cancer has been a classic landmark surgery in gynecology; therefore, this conclusion is pivotal. The current trial is designed to reconfirm whether there is a difference between laparoscopic RH and abdominal RH in cervical cancer (stages IB1, IB2, and IIA1) patient survival under stringent operation standards and consistent surgical oncologic principles. Methods/design: This is an investigator-initiated, Prospective, Randomized, Open, Blinded End-point (PROBE)-controlled non-inferiority trial. A total of 780 patients with stage IB1, IB2, and IIA1 cervical cancer will be enrolled over a period of 3 years. Patients are randomized (1:1) to either the laparoscopic RH or the abdominal RH group. Patients will then be followed up for at least 5 years. The primary endpoint will be 5-year progression-free survival, and secondary endpoints include 5-year overall survival, recurrence, and quality of life measurements. Discussion: The debate on laparoscopic versus abdominal RH is still ongoing, and high-quality evidences are needed to guide clinical practice. The study results will provide more convincing evidence-based information for early stage cervical cancer patients and their gynecologic cancer surgeons in their choice of surgical method. |
资助项目 | Shanghai Shenkang Hospital Development Center's Shenkang Promotion of Clinical Skills and Clinical Innovation in Municipal Hospitals Three-Year Action Plan (2020-2023) Major Clinical Research Project[SHDC2020CR1048B] |
WOS关键词 | MANAGEMENT ; STATISTICS ; GUIDELINES ; OUTCOMES |
WOS研究方向 | Research & Experimental Medicine |
语种 | 英语 |
出版者 | BMC |
WOS记录号 | WOS:000779599500005 |
资助机构 | Shanghai Shenkang Hospital Development Center's Shenkang Promotion of Clinical Skills and Clinical Innovation in Municipal Hospitals Three-Year Action Plan (2020-2023) Major Clinical Research Project |
内容类型 | 期刊论文 |
源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/128723] |
专题 | 中国科学院合肥物质科学研究院 |
通讯作者 | Du, Yan; Jiang, Hua |
作者单位 | 1.Fudan Univ, Obstet & Gynecol Hosp, Shanghai 200011, Peoples R China 2.Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Shanghai, Peoples R China 3.Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Shanghai, Peoples R China 4.Univ Chinese Acad Sci, Canc Hosp, Zhejiang Canc Hosp, Hangzhou, Peoples R China 5.Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Peoples R China 6.Fudan Univ, Zhongshan Hosp, Shanghai, Peoples R China 7.Fudan Univ, Childrens Hosp, Shanghai, Peoples R China |
推荐引用方式 GB/T 7714 | Wu, Xin,Qiu, Ling,Lou, Weihua,et al. A multicenter non-inferior randomized controlled study comparing the efficacy of laparoscopic versus abdominal radical hysterectomy for cervical cancer (stages IB1, IB2, and IIA1): study protocol of the LAUNCH 2 trial[J]. TRIALS,2022,23. |
APA | Wu, Xin.,Qiu, Ling.,Lou, Weihua.,Wang, Xipeng.,Zhu, Tao.,...&Jiang, Hua.(2022).A multicenter non-inferior randomized controlled study comparing the efficacy of laparoscopic versus abdominal radical hysterectomy for cervical cancer (stages IB1, IB2, and IIA1): study protocol of the LAUNCH 2 trial.TRIALS,23. |
MLA | Wu, Xin,et al."A multicenter non-inferior randomized controlled study comparing the efficacy of laparoscopic versus abdominal radical hysterectomy for cervical cancer (stages IB1, IB2, and IIA1): study protocol of the LAUNCH 2 trial".TRIALS 23(2022). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论